AZD 3043

Drug Profile

AZD 3043

Alternative Names: AZD3043; TD 4756; THRX 918661

Latest Information Update: 03 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Theravance
  • Developer AstraZeneca
  • Class Anaesthetics; Esters; Hypnosedatives
  • Mechanism of Action GABA A receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anaesthesia

Most Recent Events

  • 28 Jul 2011 Discontinued - Phase-I for Anaesthesia in Sweden (IV)
  • 28 Jul 2011 Discontinued - Phase-I for Anaesthesia in United Kingdom (IV)
  • 17 Dec 2009 AstraZeneca completes a second phase I trial in Anaesthesia in Sweden
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top